UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gefitinib Therapy in Advanced Bronchioloalveolar Carcinoma: Southwest Oncology Group Study S0126

Journal of clinical oncology, 2006-04, Vol.24 (12), p.1807-1813

2006

Volltextzugriff (PDF)

The Cyclin-Dependent Kinase Inhibitor UCN-01 Plus Cisplatin in Advanced Solid Tumors: A California Cancer Consortium Phase I Pharmacokinetic and Molecular Correlative Trial

Clinical cancer research, 2005-06, Vol.11 (12), p.4444-4450

2005

Volltextzugriff (PDF)

Impairment of the DNA Repair and Growth Arrest Pathways by p53R2 Silencing Enhances DNA Damage–Induced Apoptosis in a p53-Dependent Manner in Prostate Cancer Cells

Molecular cancer research, 2008-05, Vol.6 (5), p.808-818

2008

Volltextzugriff (PDF)

A Randomized Phase II Trial of the Matrix Metalloproteinase Inhibitor BMS-275291 in Hormone-Refractory Prostate Cancer Patients with Bone Metastases

Clinical cancer research, 2006-03, Vol.12 (5), p.1556-1563

2006

Volltextzugriff (PDF)

Low ERCC1 Expression Correlates with Prolonged Survival after Cisplatin plus Gemcitabine Chemotherapy in Non-Small Cell Lung Cancer

Clinical cancer research, 2002-07, Vol.8 (7), p.2286-2291

2002

Volltextzugriff (PDF)

Trastuzumab plus docetaxel in HER2/neu-positive non-small-cell lung cancer: a California Cancer Consortium screening and phase II trial

Clinical lung cancer, 2004-01, Vol.5 (4), p.231-236

2004

Volltextzugriff (PDF)

Epidermal growth factor receptor tyrosine kinase inhibitors plus chemotherapy: case closed or is the jury still out?

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5856-5858

2005

Volltextzugriff (PDF)

Bortezomib Plus Gemcitabine/Carboplatin as First-Line Treatment of Advanced Non-small Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S0339)

Journal of thoracic oncology, 2009-01, Vol.4 (1), p.87-92

2009

Volltextzugriff (PDF)

Pharmacodynamic Separation of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Chemotherapy in Non–Small-Cell Lung Cancer

Clinical lung cancer, 2006-05, Vol.7 (6), p.385-388

2006

Volltextzugriff (PDF)

Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: Final results from the california cancer consortium screening and Phase II trial

Cancer, 2004-05, Vol.100 (10), p.2125-2131

2004

Volltextzugriff (PDF)

The Src Inhibitor AZD0530 Blocks Invasion and May Act as a Radiosensitizer in Lung Cancer Cells

Journal of thoracic oncology, 2009-04, Vol.4 (4), p.448-454

2009

Volltextzugriff (PDF)

Current strategies in the management of hormone refractory prostate cancer

Cancer treatment reviews, 2003-06, Vol.29 (3), p.171-187

2003

Volltextzugriff (PDF)

Schedule-Dependent Apoptosis in K-ras Mutant Non–Small-Cell Lung Cancer Cell Lines Treated with Docetaxel and Erlotinib: Rationale for Pharmacodynamic Separation

Clinical lung cancer, 2007-11, Vol.8 (9), p.548-553

2007

Volltextzugriff (PDF)

Functional p53 increases prostate cancer cell survival after exposure to fractionated doses of ionizing radiation

Cancer research (Chicago, Ill.), 2003-11, Vol.63 (21), p.7190-7196

2003

Volltextzugriff (PDF)

Dehydroepiandrosterone Activates Mutant Androgen Receptors Expressed in the Androgen-Dependent Human Prostate Cancer Xenograft CWR22 and LNCaP Cells

Molecular endocrinology (Baltimore, Md.), 1997-04, Vol.11 (4), p.450-459

1997

Volltextzugriff (PDF)

Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327)

Journal of thoracic oncology, 2006-11, Vol.1 (9), p.996-1001

2006

Volltextzugriff (PDF)

Glycogen synthesis correlates with androgen-dependent growth arrest in prostate cancer

BMC urology, 2005-03, Vol.5 (1), p.6-6, Article 6

2005

Volltextzugriff (PDF)

Bronchioloalveolar carcinoma: A model for investigating the biology of epidermal growth factor receptor inhibition

Clinical cancer research, 2004-06, Vol.10 (12), p.4205s-4209s

2004

Volltextzugriff (PDF)

The Proteasome Inhibitor Bortezomib in Combination with Gemcitabine and Carboplatin in Advanced Non-small Cell Lung Cancer: A California Cancer Consortium Phase I Study

Journal of thoracic oncology, 2008-01, Vol.3 (1), p.68-74

2008

Volltextzugriff (PDF)

CWR22 : The first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar

Cancer research (Chicago, Ill.), 1996-07, Vol.56 (13), p.3042-3046

1996

Volltextzugriff (PDF)

SU5416 plus interferon α in advanced renal cell carcinoma: A phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition

Clinical cancer research, 2003-10, Vol.9 (13), p.4772-4781

2003

Volltextzugriff (PDF)

Integration of the proteasome inhibitor PS-341 (Velcade) into the therapeutic approach to lung cancer

Lung cancer, 2003-08, Vol.41, p.89-96

2003

Volltextzugriff (PDF)

Mutant DNA in Plasma of Lung Cancer Patients: Potential for Monitoring Response to Therapy

Annals of the New York Academy of Sciences, 2004-06, Vol.1022 (1), p.55-60

2004

Volltextzugriff (PDF)

HER-2/neu is overexpressed infrequently in patients with prostate carcinoma: Results from the california cancer consortium screening trial

Cancer, 2002-05, Vol.94 (10), p.2584-2589

2002

Volltextzugriff (PDF)

Survival and cell cycle kinetics of human prostate cancer cell lines after single- and multifraction exposures to ionizing radiation

International journal of radiation oncology, biology, physics, 2004-05, Vol.59 (1), p.219-227

2004

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(130)

Sprache

Englisch
(129)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(90)
Life Sciences & Biomedicine
(82)
Science & Technology
(82)
Biological And Medical Sciences
(58)
Medical Sciences
(54)
Oncology
(54)
Male
(52)
Lung Neoplasms - Drug Therapy
(22)
Middle Aged
(22)
Aged
(21)
Animals
(20)
Female
(20)
Polymerase Chain Reaction
(20)
Prostatic Neoplasms - Genetics
(19)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(18)
Pharmacology. Drug Treatments
(18)
Prostatic Neoplasms - Pathology
(18)
Tumor Cells, Cultured
(18)
Antineoplastic Agents
(17)
Base Sequence
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Clinical Cancer Research
(13)
Cancer
(10)
Clinical Lung Cancer
(9)
The Prostate
(8)
Journal Of Thoracic Oncology
(7)
Cancer Biotherapy & Radiopharmaceuticals
(6)
The Journal Of Urology
(6)
Cancer Research
(5)
Lung Cancer
(5)
Seminars In Oncology
(4)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gefitinib Therapy in Advanced Bronchioloalveolar Carcinoma: Southwest Oncology Group Study S0126

The Cyclin-Dependent Kinase Inhibitor UCN-01 Plus Cisplatin in Advanced Solid Tumors: A California Cancer Consortium Phase I Pharmacokinetic and Molecular Correlative Trial

Impairment of the DNA Repair and Growth Arrest Pathways by p53R2 Silencing Enhances DNA Damage–Induced Apoptosis in a p53-Dependent Manner in Prostate Cancer Cells

A Randomized Phase II Trial of the Matrix Metalloproteinase Inhibitor BMS-275291 in Hormone-Refractory Prostate Cancer Patients with Bone Metastases

Low ERCC1 Expression Correlates with Prolonged Survival after Cisplatin plus Gemcitabine Chemotherapy in Non-Small Cell Lung Cancer

Trastuzumab plus docetaxel in HER2/neu-positive non-small-cell lung cancer: a California Cancer Consortium screening and phase II trial

Epidermal growth factor receptor tyrosine kinase inhibitors plus chemotherapy: case closed or is the jury still out?

Bortezomib Plus Gemcitabine/Carboplatin as First-Line Treatment of Advanced Non-small Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S0339)

Pharmacodynamic Separation of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Chemotherapy in Non–Small-Cell Lung Cancer

Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: Final results from the california cancer consortium screening and Phase II trial

The Src Inhibitor AZD0530 Blocks Invasion and May Act as a Radiosensitizer in Lung Cancer Cells

Current strategies in the management of hormone refractory prostate cancer

Schedule-Dependent Apoptosis in K-ras Mutant Non–Small-Cell Lung Cancer Cell Lines Treated with Docetaxel and Erlotinib: Rationale for Pharmacodynamic Separation

Functional p53 increases prostate cancer cell survival after exposure to fractionated doses of ionizing radiation

Dehydroepiandrosterone Activates Mutant Androgen Receptors Expressed in the Androgen-Dependent Human Prostate Cancer Xenograft CWR22 and LNCaP Cells

Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327)

Glycogen synthesis correlates with androgen-dependent growth arrest in prostate cancer

Bronchioloalveolar carcinoma: A model for investigating the biology of epidermal growth factor receptor inhibition

The Proteasome Inhibitor Bortezomib in Combination with Gemcitabine and Carboplatin in Advanced Non-small Cell Lung Cancer: A California Cancer Consortium Phase I Study

CWR22 : The first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar

SU5416 plus interferon α in advanced renal cell carcinoma: A phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition

Integration of the proteasome inhibitor PS-341 (Velcade) into the therapeutic approach to lung cancer

Mutant DNA in Plasma of Lung Cancer Patients: Potential for Monitoring Response to Therapy

HER-2/neu is overexpressed infrequently in patients with prostate carcinoma: Results from the california cancer consortium screening trial

Survival and cell cycle kinetics of human prostate cancer cell lines after single- and multifraction exposures to ionizing radiation

Suchergebnisse filtern